VITia

An AI-powered app for patients to help their caregivers, family and doctors, be on the same page

https://wefunder.com/vitia

Total raised on Wefunder: 50000

Total investors: 8

Quick facts

  • Closed deal with pharmacy chain, integrated with ERP for payment and meds delivery for best UX
  • Support from lead investors with great pharma and biotech experience to close $180k pre-seed funding
  • Our pilot is Going Live! It will provide us with key proof-of-concept data and initial revenue
  • Our amazing team! We add over 60yrs experience in healthcare and over 25yrs in loyalty programs
  • Surveyed +400 doctors, 80% acknowledge need of follow up and patient education tools
  • Of 100 patients surveyed, almost 50% claimed doctors did not thoroughly explained their condition
  • Almost 50million Americans suffer complications from medication non-adherence, a $52B TAM in the US

Team profiles

Featured investor profiles

VITia

An AI-powered app for patients to help their caregivers, family and doctors, be on the same page

Funded badge
Last Funded February 2025

$50,000

raised from 8 investors

What Investors Say

LEAD INVESTOR
Invested $5,000 this round + $10,000 previously
I started my career in Pharma almost 25 years ago, with broad experiences around the globe. Leading local and global markets, and multiple therapeutic areas, a common challenge has always been how to help patients better adhere to their medical treatments. Pharma companies’ Patient Support Programs (PSPs) have helped but are still far from solving this problem that affects hundreds of thousands of patients worldwide. When Fernando first told me about VITia’s approach, I was very excited to learn about a solution that promises to really improve treatment adherence to positively impact patients’s lives. I’ve known Fernando for almost 20 years now, and have seen first-hand what he’s capable of, his strategic vision and people’s skills to build strong teams. This makes me feel confident that he and his team will reshape the way patients will manage their chronic conditions. Since my initial investment I have seen the company grow from a rough MVP to a ready-to-launch app with its first partner, I am eager to see their initial data and how it will help set the basis for a strong customer base.
What People Say